4 completed, 2 unknown, 1 active not recruiting. 7 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 4, Unknown 2, Active not recruiting 1 |
| Phase 2 | 1 | Unknown 1 |
Follow PE regimen: new trials by email Literature Review of PE regimen trials Research Report on PE regimen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer HLX10, carboplatin/cisplatin-etoposide, Thoracic radiotherapy - Limited-Stage Small Cell Lung Cancer | Phase 3 | Active not recruiting | Shanghai Henlius Biotech | 511 | 2022-05-17 | 2026-01-13 |
| Safety and Efficacy of FOLFSIM Plus Toripalimab in the Treatment of Advanced or Metastatic Neuroendocrine Carcinoma Simmtecan, 5-FU and l-LV, Toripalimab, Etoposide, Cisplatin - Neuroendocrine Carcinoma of the Bladder | Phase 2 / Phase 3 | Unknown | Peking University | 336 | 2019-06-19 | 2019-06-20 |
| Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung Cancer Durvalumab, Placebo, Cisplatin/ Etoposide - Non-Small Cell Lung Cancer | Phase 3 | Completed | AstraZeneca | 328 | 2018-03-29 | 2026-07-14 |
| A Study of Standard Treatment +/- Apatinib in Extensive Stage Small Cell Lung Cancer cisplatin, etoposide, cisplatin, etoposide, apatinib - Progression Free Survival | Phase 3 | Unknown | Qingdao University | 120 | 2017-03-01 | 2017-04-04 |
| Study Of Irinotecan Hydrochloride (Campto(R)) And Cisplatin Versus Etoposide And Cisplatin In Small Cell Lung Cancer Etoposide + cisplatin, Irinotecan + cisplatin - Small Cell Lung Carcinoma | Phase 3 | Completed | Pfizer | 485 | 2002-06-01 | 2010-02-18 |
| Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults topotecan/cisplatin, etoposide/cisplatin - Small Cell Lung Cancer | Phase 3 | Completed | GlaxoSmithKline | 760 | 2001-04-01 | 2013-08-21 |
| Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer Cisplatin + etoposide, Epirubicin + ifosfamide + etoposide - Small Cell Lung Carcinoma, Extensive Disease | Phase 3 | Completed | European Lung Cancer Working Party | 361 | 2000-04-01 | 2015-02-12 |
Small Cell Lung Carcinoma (4) · Carcinoma (1) · Carcinoma, Neuroendocrine (1) · Carcinoma, Non-Small-Cell Lung (1)
AstraZeneca (1) · European Lung Cancer Working Party (1) · GlaxoSmithKline (1) · Peking University (1) · Pfizer (1) · Qingdao University (1) · Shanghai Henlius Biotech (1)
China (4) · Czechia (4) · Poland (4) · Spain (4) · Austria (3) · Belgium (3) · France (3) · Germany (3) · Hungary (3) · Netherlands (3) · Russia (3) · Brazil (2) · Greece (2) · Italy (2) · Mexico (2)
Jean-Paul Sculier, MD, PhD (1) · Jeffrey Bradley, MD (1) · Jinming Yu, MD (1) · Lin Shen (1) · Ying Cheng (1) · Zhuang Yu, MD, Ph. D (1)
2017 (1)